NewAmsterdam Pharma Company N.V. (NAMS) Insider Trading
- $689,830.73
- $56,005,572.88
- March 2, 2026
- James N Topper
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 2, 2026 | CEO | 443,707 | $33.25 | Sell | $14,753,257.75 | |
| Feb. 26, 2026 | CEO | 183,332 | $33.71 | Sell | $6,180,121.72 | |
| Feb. 25, 2026 | CEO | 58,253 | $35.30 | Sell | $2,056,330.90 | |
| Feb. 24, 2026 | CEO | 64,708 | $36.15 | Sell | $2,339,194.20 | |
| Feb. 20, 2026 | Insider | 45,481 | $35.31 | Sell | $1,605,934.11 | |
| Sept. 15, 2025 | Director | 660 | $23.70 | Buy | $15,642.00 | |
| Sept. 9, 2025 | CAO | 150,000 | $25.83 | Sell | $3,874,500.00 | |
| Sept. 8, 2025 | Director | 1,260 | $24.99 | Buy | $31,487.40 | |
| Sept. 3, 2025 | CAO | 18,073 | $25.09 | Sell | $453,451.57 | |
| Aug. 25, 2025 | CAO | 8,269 | $24.86 | Sell | $205,567.34 | |
| Aug. 21, 2025 | Insider | 50,000 | $24.29 | Sell | $1,214,500.00 | |
| Aug. 11, 2025 | Director | 471 | $23.98 | Buy | $11,294.58 | |
| July 16, 2025 | COO | 51,043 | $21.10 | Sell | $1,077,007.30 | |
| July 15, 2025 | COO | 47,569 | $21.44 | Sell | $1,019,879.36 | |
| June 25, 2025 | Director | 1,260 | $18.26 | Buy | $23,007.60 | |
| June 24, 2025 | Director | 2,520 | $18.43 | Buy | $46,443.60 | |
| June 16, 2025 | COO | 100,000 | $19.29 | Sell | $1,929,000.00 | |
| June 16, 2025 | Director | 8,584 | $19.50 | Buy | $167,388.00 | |
| March 26, 2025 | Director | 1,135 | $22.49 | Buy | $25,526.15 | |
| March 4, 2025 | CAO | 150,000 | $20.37 | Sell | $3,055,500.00 | |
| March 4, 2025 | Director | 4,005 | $21.02 | Buy | $84,185.10 | |
| Dec. 30, 2024 | Major Shareholder | 29,846 | $25.54 | Sell | $762,266.84 | |
| Dec. 26, 2024 | Major Shareholder | 33,438 | $26.01 | Sell | $869,722.38 | |
| Dec. 23, 2024 | Major Shareholder | 25,132 | $25.49 | Sell | $640,614.68 | |
| Dec. 20, 2024 | Major Shareholder | 49,772 | $25.60 | Sell | $1,274,163.20 | |
| Dec. 18, 2024 | Major Shareholder | 100,728 | $26.10 | Sell | $2,629,000.80 | |
| Dec. 12, 2024 | Major Shareholder | 166,011 | $25.39 | Sell | $4,215,019.29 | |
| Nov. 18, 2024 | Major Shareholder | 33,273 | $25.08 | Sell | $834,486.84 | |
| Nov. 15, 2024 | Major Shareholder | 8,530 | $25.02 | Sell | $213,420.60 | |
| Oct. 1, 2024 | CAO | 45,000 | $15.72 | Sell | $707,400.00 | |
| Sept. 26, 2024 | Insider | 1,104 | $15.70 | Buy | $17,332.80 | |
| June 20, 2024 | CEO | 5,000 | $17.26 | Buy | $86,300.00 | |
| March 26, 2024 | Insider | 190,476 | $21.50 | Sell | $4,095,234.00 | |
| March 26, 2024 | Director | 8,429 | $21.50 | Buy | $181,223.50 |
Insiders are both buying and selling NewAmsterdam Pharma Company N.V. stock.
The insider traders at NewAmsterdam Pharma Company N.V. are: James N Topper, Nap B.V. Forgrowth, Louise Frederika Kooij, Michael H Davidson, Johannes Jacob Piete Kastelein, Douglas F Kling, and Juliette Berangere Audet
The most active insider trader at NewAmsterdam Pharma Company N.V. is James N Topper with 9 trades.
Michael H Davidson has sold the most NewAmsterdam Pharma Company N.V. stock with a total value of $40,082,162.32.
James N Topper has bought the most NewAmsterdam Pharma Company N.V. stock with a total value of $601,839.93.
The most recent insider trade for NewAmsterdam Pharma Company N.V. was on March 2, 2026.
The single biggest insider buy for NewAmsterdam Pharma Company N.V. was from James N Topper with a total value of $181,223.50 on March 26, 2024.
The single biggest insider sell for NewAmsterdam Pharma Company N.V. was from Michael H Davidson with a total value of $14,753,257.75 on March 2, 2026.